Predictive Oncology Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
POAI Nasdaq 3841 https://predictive-oncology.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Predictive Oncology Inc

Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention - May 23rd, 2023 12:30 pm
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update - May 15th, 2023 9:15 pm
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023 - May 8th, 2023 12:00 pm
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors - May 2nd, 2023 9:10 pm
Predictive Oncology Announces Reverse Stock Split - Apr 20th, 2023 9:10 pm
Predictive Oncology Adjourns Special Meeting of Stockholders - Apr 17th, 2023 10:00 pm
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board - Apr 4th, 2023 12:30 pm
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy - Mar 30th, 2023 12:30 pm
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update - Mar 21st, 2023 9:15 pm
Predictive Oncology partners with Cancer Research Horizons to leverage AI for new cancer drugs - Mar 21st, 2023 5:38 pm
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs - Mar 17th, 2023 11:00 am
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock - Mar 16th, 2023 9:15 pm
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner - Mar 14th, 2023 12:30 pm
Predictive Oncology Issues Letter to Shareholders - Mar 9th, 2023 1:30 pm
Predictive Oncology partners with Cvergenx to create new genomics-based AI radiation therapy - Mar 1st, 2023 12:14 pm
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence - Feb 23rd, 2023 1:30 pm
Predictive Oncology appoints Pamela Bush as new chief business officer - Feb 21st, 2023 7:04 pm
Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiatives - Feb 21st, 2023 1:30 pm
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer - Feb 3rd, 2023 1:31 pm
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive Oncology - Jan 12th, 2023 1:30 pm